繁
|
简
Financial Reports
Presentations
Corporate Governance
Announcements and Notices
Returns on Share Capital
Circulars
Prospectus
Press Releases
Shareholder Services
Corporate Information
Please Select Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2024
02 Dec 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
02 Dec 24
VOLUNTARY ANNOUNCEMENT - TWO DRUGS INCLUDED IN NATIONAL REIMBURSEMENT DRUG LIST OF CHINA
25 Nov 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
05 Nov 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
21 Oct 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Oct 24
UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
14 Oct 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
09 Sep 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
02 Sep 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
28 Aug 24
Interim Dividend for the six months ended 30 June 2024
28 Aug 24
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
28 Aug 24
List of Directors and their Role and Function
28 Aug 24
APPOINTMENT OF EXECUTIVE DIRECTOR
27 Aug 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
26 Aug 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
21 Aug 24
INSIDE INFORMATION - UPDATE ON TENDER REGARDING PROCUREMENT OF BROMHEXINE HYDROCHLORIDE INJECTION
16 Aug 24
DATE OF BOARD MEETING
14 Aug 24
INSIDE INFORMATION - CREDIT RATING ON TENDER REGARDING PROCUREMENT OF BROMHEXINE HYDROCHLORIDE INJECTION AND RESUMPTION OF TRADING
14 Aug 24
TRADING HALT
13 Aug 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
07 Aug 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
26 Jul 24
REVISION OF ANNUAL CAP FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE MASTER SALE AND PURCHASE AGREEMENT
23 Jul 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Jul 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
16 Jul 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
05 Jul 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
28 Jun 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 Jun 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Jun 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Jun 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
07 Jun 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
03 Jun 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
03 Jun 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 May 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 May 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
28 May 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 May 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
22 May 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
21 May 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 May 24
POLL RESULTS OF ANNUAL GENERAL MEETING 2024
13 May 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Apr 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Apr 24
Notice of Annual General Meeting
16 Apr 24
UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2024
08 Apr 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
03 Apr 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 Mar 24
Final Dividend for the year ended 31 December 2023
27 Mar 24
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
25 Mar 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
20 Mar 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
15 Mar 24
DATE OF BOARD MEETING
01 Mar 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
29 Feb 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 Feb 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Feb 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
19 Feb 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
31 Jan 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Jan 24
Arrangement of Electronic Dissemination of Corporate Communications
26 Jan 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Jan 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
19 Jan 24
List of Directors and their Role and Function
19 Jan 24
APPOINTMENT OF NON-EXECUTIVE DIRECTOR
18 Jan 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
16 Jan 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
09 Jan 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
05 Jan 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
02 Jan 24
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
2023
27 Dec 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
13 Dec 23
CONTINUING CONNECTED TRANSACTIONS - (1) MASTER SALE AND PURCHASE AGREEMENT (2) MASTER PRODUCTS MANUFACTURING AND TRANSPORTATION SERVICES AGREEMENT (3) MASTER RESEARCH & DEVELOPMENT SERVICES AGREEMENT
01 Dec 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 Nov 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
23 Nov 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
22 Nov 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
09 Nov 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
08 Nov 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
07 Nov 23
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALISED MEDICINES PROCUREMENT
01 Nov 23
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
01 Nov 23
RESIGNATION OF NON-EXECUTIVE DIRECTOR
31 Oct 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Oct 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 Oct 23
UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023
26 Oct 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 Oct 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 Oct 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
20 Oct 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Oct 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
11 Oct 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
09 Oct 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 Sep 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
15 Sep 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
04 Sep 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
01 Sep 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
29 Aug 23
Interim Dividend for the six months ended 30 June 2023
29 Aug 23
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
23 Aug 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Aug 23
DATE OF BOARD MEETING
14 Aug 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 Jul 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
21 Jul 23
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON MARKET PURSUANT TO RESTRICTED SHARE AWARD SCHEME
19 Jul 23
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON MARKET PURSUANT TO RESTRICTED SHARE AWARD SCHEME
14 Jul 23
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON MARKET PURSUANT TO RESTRICTED SHARE AWARD SCHEME
13 Jul 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
12 Jul 23
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON MARKET PURSUANT TO RESTRICTED SHARE AWARD SCHEME
06 Jul 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
29 Jun 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
13 Jun 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
02 Jun 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 May 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
19 May 23
List of Directors and their Role and Function
19 May 23
POLL RESULTS OF ANNUAL GENERAL MEETING 2023 AND RETIREMENT OF DIRECTOR
17 May 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
12 May 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
11 May 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
08 May 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
28 Apr 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
25 Apr 23
UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2023
20 Apr 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Apr 23
Notice of Annual General Meeting
14 Apr 23
PRE-LISTING TUTORING APPLICATION IN RELATION TO PROPOSED LISTING OF JIANGSU BEST NEW MEDICAL ON THE BEIJING STOCK EXCHANGE
13 Apr 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
11 Apr 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Mar 23
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALISED MEDICINES PROCUREMENT
28 Mar 23
Final Dividend for the year ended 31 December 2022
28 Mar 23
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022
27 Mar 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 Mar 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
24 Mar 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Mar 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
22 Mar 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Mar 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
16 Mar 23
DATE OF BOARD MEETING
06 Mar 23
POSITIVE PROFIT ALERT
20 Feb 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
06 Feb 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
02 Feb 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Jan 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
19 Jan 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT AND BUSINESS DEVELOPMENT
13 Jan 23
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 13 JANUARY 2023
09 Jan 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
05 Jan 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT AND BUSINESS DEVELOPMENT
04 Jan 23
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
2022
28 Dec 22
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
28 Dec 22
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN THE COMPOSITION OF BOARD COMMITTEES
28 Dec 22
Remuneration Committee Terms of Reference
20 Dec 22
NOTICE OF EXTRAORDINARY GENERAL MEETING
18 Dec 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
13 Dec 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
28 Nov 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
14 Nov 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
28 Oct 22
(1) PROPOSED ADOPTION OF NEW SHARE OPTION SCHEME AND (2) SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSURES RELATING TO THE 2012 SHARE OPTION SCHEME
19 Oct 22
UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2022
10 Oct 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
26 Sep 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
13 Sep 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
07 Sep 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
05 Sep 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
29 Aug 22
Interim Dividend for the six months ended 30 June 2022
29 Aug 22
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022
17 Aug 22
DATE OF BOARD MEETING
01 Aug 22
POSITIVE PROFIT ALERT
13 Jul 22
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
06 Jul 22
QUOTATION OF JIANGSU BEST NEW MEDICAL ON THE NEEQ
04 Jul 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Jun 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
21 Jun 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
14 Jun 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 May 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 May 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 May 22
AMENDED AND RESTATED ARTICLES OF ASSOCIATION
23 May 22
POLL RESULTS OF ANNUAL GENERAL MEETING 2022
16 May 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
13 May 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
28 Apr 22
APPROVAL OF QUOTATION OF JIANGSU BEST NEW MEDICAL ON THE NEEQ
19 Apr 22
Notice of Annual General Meeting
19 Apr 22
UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2022
06 Apr 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
29 Mar 22
PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION
29 Mar 22
Final Dividend for the year ended 31 December 2021
29 Mar 22
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
18 Mar 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Mar 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Mar 22
DATE OF BOARD MEETING
09 Mar 22
DISCLOSEABLE TRANSACTION - ACQUISITION OF TARGET COMPANY
07 Mar 22
BUSINESS UPDATE - LETTER OF INTENT
09 Feb 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
28 Jan 22
POSSIBLE SPIN-OFF AND SEPARATE QUOTATION OF JIANGSU BEST NEW MEDICAL ON THE NEEQ
11 Jan 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
10 Jan 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
06 Jan 22
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
2021
28 Dec 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
14 Dec 21
VOLUNTARY ANNOUNCEMENT - HYDROXYETHYL STARCH 130 AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
13 Dec 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON POSSIBLE SPIN-OFF OF JIANGSU BEST NEW MEDICAL
20 Oct 21
UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2021
18 Oct 21
VOLUNTARY ANNOUNCEMENT - POSSIBLE SPIN-OFF AND QUOTATION AND/OR LISTING ON A STOCK EXCHANGE IN MAINLAND CHINA
11 Oct 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Sep 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
10 Sep 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
03 Sep 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
27 Aug 21
List of Directors and their Role and Function
27 Aug 21
APPOINTMENT AND RESIGNATION OF EXECUTIVE DIRECTORS
27 Aug 21
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021
25 Aug 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Aug 21
DATE OF BOARD MEETING
29 Jul 21
DISCLOSEABLE TRANSACTION - ACQUISITION OF LISTED SECURITIES
28 Jul 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Jul 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
06 Jul 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
02 Jul 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Jun 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 Jun 21
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
27 May 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
21 May 21
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING
21 May 21
POLL RESULTS OF ANNUAL GENERAL MEETING 2021
03 May 21
NOTICE OF EXTRAORDINARY GENERAL MEETING
30 Apr 21
UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2021
19 Apr 21
Notice of Annual General Meeting
14 Apr 21
CONTINUING CONNECTED TRANSACTIONS - MASTER SALE AND PURCHASE AGREEMENT
12 Apr 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Mar 21
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020
25 Mar 21
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Mar 21
DATE OF BOARD MEETING
12 Mar 21
VOLUNTARY ANNOUNCEMENT - METRONIDAZOLE AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
01 Mar 21
CHANGE OF ADDRESS OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS
26 Feb 21
PROFIT WARNING
03 Feb 21
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
21 Jan 21
VOLUNTARY ANNOUNCEMENT - FLUCONAZOLE AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
13 Jan 21
VOLUNTARY ANNOUNCEMENT - CIPROFLOXACIN LACTATE AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
12 Jan 21
GRANT OF SHARE OPTIONS
2020
30 Dec 20
VOLUNTARY ANNOUNCEMENT - AMBROXOL HYDROCHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
02 Dec 20
VOLUNTARY ANNOUNCEMENT - MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
10 Nov 20
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
05 Nov 20
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
30 Oct 20
UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2020
14 Oct 20
CHANGE OF NAME OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS
25 Aug 20
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020
21 Aug 20
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
19 Aug 20
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT AND PRODUCT DEVELOPMENT
13 Aug 20
DATE OF BOARD MEETING
07 Aug 20
PROFIT WARNING
29 Jul 20
VOLUNTARY ANNOUNCEMENT - INTRA-GROUP RESTRUCTURING FOR POSSIBLE SPIN-OFF AND SEPARATE LISTING
22 Jul 20
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
20 Jul 20
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
22 May 20
POLL RESULTS OF ANNUAL GENERAL MEETING 2020
24 Apr 20
CONTINUING CONNECTED TRANSACTION - REVISION OF ANNUAL CAP
20 Apr 20
Notice of Annual General Meeting
20 Apr 20
UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2020
30 Mar 20
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
23 Mar 20
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Mar 20
DATE OF BOARD MEETING
24 Feb 20
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
20 Feb 20
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
19 Feb 20
INSIDE INFORMATION - Inclusion of Abidol in Diagnosis and Treatment Program for Novel Coronavirus Infected Pneumonia (Trial Version 6)
06 Feb 20
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
05 Feb 20
INSIDE INFORMATION, UNUSUAL TRADING VOLUME AND PRICE MOVEMENTS, RESUMPTION OF TRADING
05 Feb 20
Trading Halt
29 Jan 20
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
15 Jan 20
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
2019
02 Dec 19
INSIDE INFORMATION - LAND REPURCHASE AGREEMENT
21 Oct 19
UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019
30 Sep 19
CONTINUING CONNECTED TRANSACTION - REVISION OF ANNUAL CAP
17 Sep 19
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
26 Aug 19
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2019
14 Aug 19
DATE OF BOARD MEETING
10 Jun 19
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 May 19
VOLUNTARY ANNOUNCEMENT - FLUCONAZOLE TABLETS PASS CONSISTENCY EVALUATION
08 May 19
POLL RESULTS OF ANNUAL GENERAL MEETING 2019
17 Apr 19
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Apr 19
UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2019
28 Mar 19
Notice of Annual General Meeting
13 Mar 19
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
05 Mar 19
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
01 Mar 19
DATE OF BOARD MEETING
18 Feb 19
POSITIVE PROFIT ALERT
07 Jan 19
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
2018
28 Dec 18
ADOPTION OF RESTRICTED SHARE AWARD SCHEME
31 Oct 18
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
18 Oct 18
UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2018
27 Aug 18
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2018
15 Aug 18
DATE OF BOARD MEETING
06 Aug 18
POSITIVE PROFIT ALERT
13 Jul 18
VOLUNTARY ANNOUNCEMENT RECOGNITION AS THE NATIONAL ENTERPRISE TECHNOLOGY CENTRE
20 Jun 18
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
04 Jun 18
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 May 18
VOLUNTARY ANNOUNCEMENT - RECEIVED THE SCIENCE AND TECHNOLOGY PROGRESS AWARD
16 May 18
POLL RESULTS OF ANNUAL GENERAL MEETING 2018
25 Apr 18
CONTINUING CONNECTED TRANSACTION - MASTER SALE AND PURCHASE AGREEMENT
24 Apr 18
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
16 Apr 18
UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2018
12 Apr 18
Notice of Annual General Meeting
27 Mar 18
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2017
22 Mar 18
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
15 Mar 18
DATE OF BOARD MEETING
05 Mar 18
VOLUNTARY ANNOUNCEMENT - UPDATES ON TECHNOLOGY AND PRODUCT DEVELOPMENT
28 Feb 18
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 Feb 18
POSITIVE PROFIT ALERT
2017
11 Dec 17
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 Nov 17
List of Directors and their Role and Function
24 Nov 17
APPOINTMENT OF NON-EXECUTIVE DIRECTOR
18 Oct 17
VOLUNTARY ANNOUNCEMENT - COOPERATION AGREEMENT
10 Oct 17
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2017
30 Aug 17
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
23 Aug 17
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017
11 Aug 17
DATE OF BOARD MEETING
01 Aug 17
POSITIVE PROFIT ALERT
21 Jul 17
CONTINUING CONNECTED TRANSACTION - MASTER SALE AND PURCHASE AGREEMENT
24 May 17
POLL RESULTS OF ANNUAL GENERAL MEETING 2017
18 May 17
CHANGE OF NAME AND ADDRESS OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS
18 Apr 17
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2017
12 Apr 17
Notice of Annual General Meeting
29 Mar 17
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016
17 Mar 17
DATE OF BOARD MEETING
2016
29 Dec 16
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR ESTABLISHMENT OF NATIONAL AND LOCAL JOINT ENGINEERING LABORATORY
21 Nov 16
TEMPORARY SUSPENSION OF PRODUCTION AND RESUMPTION OF TRADING
21 Nov 16
TRADING HALT
27 Oct 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Oct 16
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2016
17 Oct 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
31 Aug 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
30 Aug 16
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2016
18 Aug 16
DATE OF BOARD MEETING
14 Jul 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
01 Jun 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
27 May 16
POLL RESULTS OF ANNUAL GENERAL MEETING 2016
29 Apr 16
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2016
25 Apr 16
Notice of Annual General Meeting
22 Apr 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
21 Apr 16
PROPOSED CHANGE OF AUDITOR
15 Apr 16
PROPOSED GRANT OF SHARE OPTIONS
11 Apr 16
UPDATE ON DISCLOSEABLE TRANSACTION - ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL IN JIANGSU BOSHENG YI YONG XIN CAI LIAO CO., LTD. - COMPLETION OF FURTHER SUPPLEMENTAL AGREEMENT FOR ISSUE OF CONSIDERATION SHARES
31 Mar 16
UPDATE ON DISCLOSEABLE TRANSACTION - ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL IN JIANGSU BOSHENG YI YONG XIN CAI LIAO CO., LTD. - FURTHER SUPPLEMENTAL AGREEMENT FOR ISSUE OF CONSIDERATION SHARES
30 Mar 16
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2015
23 Mar 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
16 Mar 16
DATE OF BOARD MEETING
15 Mar 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
07 Mar 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
24 Feb 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
02 Feb 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
01 Feb 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
20 Jan 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
06 Jan 16
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
2015
29 Dec 15
UPDATE ON DISCLOSEABLE TRANSACTION - ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL IN JIANGSU BOSHENG YI YONG XIN CAI LIAO CO., LTD.
18 Dec 15
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
17 Nov 15
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
26 Oct 15
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR ESTABLISHMENT OF POST-DOCTORAL SCIENTIFIC RESEARCH WORKSTATION
19 Oct 15
GRANT OF SHARE OPTIONS
16 Oct 15
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2015
01 Sep 15
DISCLOSEABLE TRANSACTION - ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL IN JIANGSU BOSHENG YI YONG XIN CAI LIAO CO., LTD.
31 Aug 15
CLOSING, AND RESULTS, OF THE CASH OFFER BY BNP PARIBAS SECURITIES (ASIA) LIMITED ON BEHALF OF SSY GROUP LIMITED TO BUY-BACK UP TO 150,000,000 SHARES FOR HK$3.30 IN CASH PER SHARE
31 Aug 15
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2015
20 Aug 15
DATE OF BOARD MEETING
19 Aug 15
UNCONDITIONAL CASH OFFER BY BNP PARIBAS SECURITIES (ASIA) LIMITED ON BEHALF OF SSY GROUP LIMITED TO BUY-BACK UP TO 150,000,000 SHARES FOR HK$3.30 IN CASH PER SHARE
17 Aug 15
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING AND FULFILLMENT OF CONDITIONS OF THE OFFER
31 Jul 15
DESPATCH OF OFFER DOCUMENT AND EXPECTED TIMETABLE OF THE OFFER
31 Jul 15
NOTICE OF THE EXTRAORDINARY GENERAL MEETING
24 Jul 15
CLARIFICATION ANNOUNCEMENT ON THE DELAY IN DESPATCH OF OFFER DOCUMENT
23 Jul 15
DELAY IN DESPATCH OF OFFER DOCUMENT
02 Jul 15
CONDITIONAL CASH OFFER BY BNPP SECURITIES ON BEHALF OF SSY GROUP LIMITED TO BUY-BACK UP TO 150,000,000 SHARES FOR HK$3.30 IN CASH PER SHARE AND APPLICATION FOR WHITEWASH WAIVER AND RESUMPTION OF TRADING
24 Jun 15
TRADING HALT
15 Jun 15
BUSINESS UPDATE
09 Jun 15
CHANGE OF COMPANY NAME, STOCK SHORT NAME AND COMPANY WEBSITE
15 May 15
POLL RESULTS OF ANNUAL GENERAL MEETING 2015
30 Apr 15
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2015
15 Apr 15
NOTICE OF ANNUAL GENERAL MEETING
01 Apr 15
CHANGE OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
27 Mar 15
PROPOSED CHANGE OF COMPANY NAME
27 Mar 15
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2014
11 Mar 15
DATE OF BOARD MEETING
09 Feb 15
POSITIVE PROFIT ALERT
04 Feb 15
FORMATION OF JOINT VENTURE COMPANY
22 Jan 15
BUSINESS UPDATE
2014
15 Dec 14
List of Directors and their Role and Function
15 Dec 14
RESIGNATION OF EXECUTIVE DIRECTOR AND APPOINTMENT OF EXECUTIVE DIRECTOR
03 Nov 14
ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES COMPLETION OF THE DISPOSAL AGREEMENT
30 Oct 14
CLARIFICATION ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES
30 Oct 14
TRADING HALT
29 Oct 14
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2014
22 Oct 14
ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES COMPLETION OF THE DISPOSAL AGREEMENT
17 Oct 14
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
10 Oct 14
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 10 OCTOBER 2014
19 Sep 14
NOTICE OF EXTRAORDINARY GENERAL MEETING
15 Sep 14
BUSINESS UPDATE
29 Aug 14
MAJOR AND CONNTECTED TRANSACTION - DISPOSAL OF ENTIRE ISSUED SHARE CAPITAL OF XI'AN LIJUN PHARMACEUTICAL CO., LTD.
28 Aug 14
CLARIFICATION ANNOUNCEMENT
28 Aug 14
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2014
15 Aug 14
NOTICE OF BOARD MEETING
06 Aug 14
POSITIVE PROFIT ALERT
24 Jun 14
EXERCISE OF SHARE OPTIONS
11 Jun 14
STATUS OF WAIVER ON THE SPECIFIC PERFORMANCE COVENANT UNDER LOAN AGREEMENT
09 Jun 14
STATUS OF SPECIFIC PERFORMANCE COVENANT UNDER LOAN AGREEMENT
05 Jun 14
ANNOUNCEMENT
05 Jun 14
List of Directors and their Role and Function
05 Jun 14
(1) SALE OF EXISTING SHARES BY A SUBSTANTIAL SHAREHOLDER (2) CHANGE IN SHAREHOLDING (3) RESIGNATION OF DIRECTORS AND CHANGE OF AUTHORIZED REPRESENTATIVE
23 May 14
POLL RESULTS OF THE ANNUAL GENERAL MEETING 2014
24 Apr 14
NOTICE OF ANNUAL GENERAL MEETING
23 Apr 14
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2014
08 Apr 14
CLARIFICATION ANNOUNCEMENT
31 Mar 14
UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS
31 Mar 14
Final Dividend
28 Mar 14
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2013
14 Mar 14
DATE OF BOARD MEETING
12 Mar 14
POSITIVE PROFIT ALERT
2013
01 Nov 13
ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES TERMINATION OF THE SALES AND PURCHASE AGREEMENTS
22 Oct 13
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2013
30 Aug 13
ANNOUNCEMENT FURTHER EXTENSIONS OF LONG STOP DATES OF SALE AND PURCHASE AGREEMENTS
30 Aug 13
BOARD DIVERSITY POLICY ADOPTED ON 1 SEPTEMBER 2013
28 Aug 13
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2013
13 Aug 13
NOTICE OF BOARD MEETING
07 Aug 13
POSITIVE PROFIT ALERT
02 Aug 13
ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES
30 Jul 13
ANNOUNCEMENT CHANGE OF INFORMATION OF DIRECTOR
01 Jul 13
ANNOUNCEMENT EXTENSIONS OF LONG STOP DATES OF SALE AND PURCHASE AGREEMENTS
24 May 13
POLL RESULTS OF THE ANNUAL GENERAL MEETING 2013
10 May 13
CHANGE OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND ALTERNATE AUTHORISED REPRESENTATIVE
06 May 13
ANNOUNCEMENT PURSUANT TO RULE 13.09(2)(a) OF THE LISTING RULES
11 Apr 13
NOTICE OF ANNUAL GENERAL MEETING
10 Apr 13
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2013
28 Mar 13
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2012
18 Mar 13
DATE OF BOARD MEETING
25 Feb 13
POSITIVE PROFIT ALERT
03 Jan 13
CLARIFICATION ANNOUNCEMENT
2012
28 Dec 12
ANNOUNCEMENT PURSUANT TO RULE 13.09 OF THE LISTING RULES
18 Dec 12
RENEWAL OF CONTINUING CONNECTED TRANSACTION
18 Dec 12
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
18 Dec 12
RESIGNATION OF EXECUTIVE DIRECTORS AND CHANGE OF AUTHORIZED REPRESENTATIVE
30 Nov 12
CHANGE OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS
19 Nov 12
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
17 Oct 12
GENERAL DISCLOSURE PURSUANT TO RULE 13.18 OF THE LISTING RULES
16 Oct 12
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2012
16 Oct 12
COMPLETION OF THE BONUS ISSUE AND ADJUSTMENTS TO THE SHARE OPTIONS AS A RESULT OF THE BONUS ISSUE
20 Sep 12
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 20 SEPTEMBER 2012
30 Aug 12
NOTICE OF EXTRAORDINARY GENERAL MEETING
21 Aug 12
PROPOSED BONUS ISSUE OF SHARES AND CHANGE IN BOARD LOT SIZE
21 Aug 12
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2012
14 Aug 12
PRICE-SENSITIVE ANNOUNCEMENT AND RESUMPTION OF TRADING
14 Aug 12
ANNOUNCEMENT
13 Aug 12
SUSPENSION OF TRADING
09 Aug 12
DATE OF BOARD MEETING
25 May 12
POLL RESULTS OF ANNUAL GENERAL MEETING 2012
03 May 12
GRANT OF OPTIONS
20 Apr 12
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2012
10 Apr 12
List of Directors and their Role and Function
05 Apr 12
RESIGNATION OF EXECUTIVE DIRECTOR
02 Apr 12
NOTICE OF ANNUAL GENERAL MEETING
23 Mar 12
List of Directors and their Role and Function
23 Mar 12
Nomination Committee Terms of Reference
23 Mar 12
Remuneration Committee Terms of Reference
23 Mar 12
Audit Committee Terms of Reference
23 Mar 12
Memorandum and Article of Association
23 Mar 12
FORMATION OF NOMINATION COMMITTEE
23 Mar 12
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2011
13 Mar 12
DATE OF BOARD MEETING
23 Feb 12
PROFIT WARNING
2011
28 Oct 11
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2011
24 Oct 11
DATE OF BOARD MEETING
17 Oct 11
RESIGNATION OF NON-EXECUTIVE DIRECTOR
26 Aug 11
CHANGE OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND ALTERNATE AUTHORISED REPRESENTATIVE
26 Aug 11
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2011
16 Aug 11
DATE OF BOARD MEETING
29 Jul 11
RESIGNATION OF DIRECTOR AND CHANGE OF AUTHORIZED REPRESENTATIVE
27 May 11
POLL RESULTS OF ANNUAL GENERAL MEETING 2011
27 Apr 11
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2011
07 Apr 11
NOTICE OF ANNUAL GENERAL MEETING
25 Mar 11
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2010
15 Mar 11
DATE OF BOARD MEETING
2010
29 Oct 10
DISCLOSEABLE TRANSACTION IN RELATION TO THE PROPOSED FORMATION OF A JOINT VENTURE
29 Oct 10
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2010
26 Oct 10
DATE OF BOARD MEETING
04 Oct 10
VOLUNTARY ANNOUNCEMENT
23 Aug 10
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2010
09 Aug 10
DATE OF BOARD MEETING
21 Jul 10
MEMORANDUM OF UNDERSTANDING IN RESPECT OF FORMATION OF JOINT VENTURE
13 Jul 10
PLACEMENT OF EXISTING SHARES
28 May 10
POLL RESULTS OF ANNUAL GENERAL MEETING 2010
30 Apr 10
ANNOUNCEMENT OF TURNOVER AND GROSS PROFIT INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2010
27 Apr 10
COMPLETION OF THE PLACING AND SALE OF EXISTING SHARES AND SUBSCRIPTION FOR NEW SHARES
23 Apr 10
DATE OF BOARD MEETING
15 Apr 10
PLACING AND SALE OF EXISTING SHARES AND SUBSCRIPTION FOR NEW SHARES AND RESUMPTION OF TRADING
14 Apr 10
SUSPENSION OF TRADING
07 Apr 10
NOTICE OF ANNUAL GENERAL MEETING
30 Mar 10
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2009
16 Mar 10
DATE OF BOARD MEETING
25 Feb 10
PROFIT GROWTH
2009
21 Dec 09
RENEWAL OF CONTINUING CONNECTED TRANSACTIONS
18 Dec 09
Announcement
14 Dec 09
ANNOUNCEMENT CANCELLATION OF RMB16,000,000 HK$ SETTLED ZERO COUPON CONVERTIBLE BONDS DUE 2010
14 Dec 09
GENERAL DISCLOSURE PURSUANT TO RULE 13.18 OF THE LISTING RULES
06 Nov 09
ANNOUNCEMENT AND RESUMPTION OF TRADING
06 Nov 09
SUSPENSION OF TRADING
28 Aug 09
NOTICE TO BONDHOLDERS HK$ SETTLED RMB160,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2010
28 Aug 09
ANNOUNCEMENT - ADJUSTMENT OF CONVERSION PRICE OF HK$ SETTLED ZERO COUPON CONVERTIBLE BONDS DUE 2010
28 Aug 09
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2009
29 Jul 09
CHANGE OF DIRECTORS
27 Jul 09
DATE OF BOARD MEETING
13 Jul 09
PROFIT GROWTH
19 Jun 09
GENERAL DISCLOSURE PURSUANT TO RULE 13.18 OF THE LISTING RULES
08 Jun 09
ANNOUNCEMENT - CANCELLATION OF RMB20,000,000 HK$ SETTLED ZERO COUPON CONVERTIBLE BONDS DUE 2010
05 Jun 09
POLL RESULTS OF ANNUAL GENERAL MEETING
29 Apr 09
NOTICE OF ANNUAL GENERAL MEETING
26 Apr 09
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2008
06 Apr 09
DATE OF BOARD MEETING
2008
09 Dec 08
DISCLOSEABLE TRANSACTION ACQUISITION OF LAND-USE RIGHTS IN THE PRC
26 Sep 08
ANNOUNCEMENT - CANCELLATION OF RMB 30,000,000 HK$ SETTLED ZERO COUPON CONVERTIBLE BONDS DUE 2010
16 Sep 08
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2008
02 Sep 08
DATE OF BOARD MEETING
01 Sep 08
APPOINTMENT OF EXECUTIVE DIRECTOR
09 Jul 08
Announcement - Unusual Volume Movements
20 Jun 08
APPOINTMENT OF CHIEF FINANCIAL OFFICER, QUALIFIED ACCOUNTANT AND COMPANY SECRETARY
30 May 08
RETIREMENT OF DIRECTOR, CHANGE OF AUTHORIZED RESPRESENTATIVE, RESIGNATION OF CHIEF FINANCIAL OFFICER,QUALIFIED ACCOUNTANT AND COMPANY SECRETARY
29 Apr 08
Notice of Annual General Meeting
25 Apr 08
ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2007
11 Apr 08
Date of Board Meeting
26 Feb 08
UNUSUAL PRICE MOVEMENTS
2007
20 Dec 07
CONTINUING CONNECTED TRANSACTIONS
10 Sep 07
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2007
29 Aug 07
Date of Board Meeting
28 Aug 07
SUBDIVISION OF SHARES INCREASE IN AUTHORIZED ORDINARY SHARE CAPITAL REFRESHMENT OF GENERAL MANDATE TO ISSUE SHARES AND RE-ELECTION OF DIRECTORS RESULTS OF EXTRAORDINARY GENERAL MEETING
28 Aug 07
Notice To Bondholders HK$ Settled RMB160,000,000 Zero Coupon Convertible Bonds Due 2010
20 Aug 07
Connected Transaction
16 Aug 07
Notice To Bondholders HK$ Settled RMB160,000,000 Zero Coupon Convertible Bonds Due 2010
09 Aug 07
NOTICE OF EXTRAORDINARY GENERAL MEETING
03 Aug 07
PROPOSALS FOR SUBDIVISION OF SHARES AND CHANGE OF BOARD LOT SIZE INCREASE IN AUTHORIZED ORDINARY SHARE CAPITAL AND REFRESHMENT OF GENERAL MANDATE TO ISSUE AND REPURCHASE SHARES
26 Jul 07
RE-DESIGNATION OF EXECUTIVE DIRECTOR, APPOINTMENT OF EXECUTIVE DIRECTORS AND APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
04 Jul 07
Loan Agreement with Specific Performance Covenant GENERAL DISCLOSURE PURSUANT TO RULE 13.18 OF THE LISTING RULES
26 Jun 07
MAJOR AND CONNECTED TRANSACTION RESULTS OF EXTRAORDINARY GENERAL MEETING
11 Jun 07
Notice of Extraordinary General Meeting
08 Jun 07
Announcement - Placing of Existing Shares
22 May 07
Further Delay in despatch of Circular
21 May 07
Clarification Announcement
17 May 07
Proposed Issue of HK$ Settled RMB 160,000,000 Zero Coupon Convertible Bonds Due 2010 and Resumption of Trading
30 Apr 07
Notice of Annual General Meeting
26 Apr 07
Announcement of Final Results for the Year Ended 31 December 2006
20 Apr 07
Delay in Despatch of Circular
16 Apr 07
Change of Address
30 Mar 07
Major and Connected Transaction - Acquisition of the Entire Issued Share Capital and the Shareholder's Loan of New Orient Investments Limited
2006
21 Nov 06
Memorandum of Understanding in Respect of Proposed Acquisition of 55% Equity Interest in SunStone (Tangshan) Pharmaceutical Co., Ltd.
07 Nov 06
Change of Registered Address in Cayman Islands
25 Sep 06
Appointment of Executive Director
01 Sep 06
Announcement of Interim Results for the Six Months Ended 30 June 2006
23 Jun 06
Discloseable and Connected Transaction; Results of Extraordinary General Meeting and Satisfaction of Conditions
23 Jun 06
Discloseable and Connected Transaction; Results of Extraordinary General Meeting and Satisfaction of Conditions
05 Jun 06
Notice of EGM
16 May 06
Discloseable and Connected Transaction; Resumption of Trading
24 Mar 06
Notice of Annual General Meeting
20 Mar 06
Announcement of Final Results for the Year Ended 31 December 2005
21 Feb 06
Clarification Announcement
10 Jan 06
Stabilising Action and the End of Stabilisation Period
2005
21 Dec 05
Exercise of Over-Allotment Option
09 Dec 05
IPO Allotment Results
02 Dec 05
Listing on the Main Board of The Stock Exchange of Hong Kong Limited by way of Placing and Public Offer